Literature DB >> 25041179

Usefulness of T(peak) -T(end) interval to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic right ventricular outflow tract tachycardia.

Ebru Golcuk1, Kivanc Yalin, Ahmet Kaya Bilge, Ali Elitok, Tolga Aksu, Taylan Akgun, Ekrem Bilal Karaayvaz, Samim Emet, Kamil Adalet.   

Abstract

BACKGROUND: The two predominant etiologies of right ventricular tachycardia (VT) are arrhythmogenic right ventricular cardiomyopathy (ARVC) and idiopathic VT arising from the right ventricular outflow tract (RVOT). Discrimination between these two entities is critical, as their prognoses and therapeutic options differ. The Tpeak -Tend (Tpe) interval reflects the transmural repolarization dispersion and its prolongation is associated with high mortality.
METHODS: We compared the sinus rhythm electrocardiogram (ECG) of 43 patients (24 male, 43 ± 16 years) with VT originating from right ventricle. Five patients under antiarrhythmic drug therapy were excluded. Tpe interval was measured in each precordial leads and compared among patients with ARVC and RVOT-VT.
RESULTS: Twenty-five patients (16 male, 42 ± 16 years) met the Task Force criteria for the diagnosis of ARVC, and 13 patients (seven male, 45 ± 14 years) had idiopathic RVOT tachycardia. Patients with ARVC had significantly prolonged Tpe intervals in all precordial leads compared to patients with idiopathic RVOT VT (137.1 ± 32.6 ms vs 93.8 ± 16.9 ms; P < 0.001 in V1, 133.2 ± 35.5 ms vs 104.7 ± 16.9 ms; P = 0.01 in V2, 125.7 ± 31.5 ms vs 99.1 ± 19.6 ms; P = 0.09 in V3, 121.9 ± 26.5 ms vs 92.3 ± 19.7 ms; P = 0.001 in V4, 123.1 ± 26.5 ms vs 99.5 ± 20:1 ms; P = 0.04 in V5 and 126.9 ± 32.2 ms vs 89 ± 11.3 ms; P < 0.001 in V6, respectively). For the diagnosis of ARVC, Tpe cut-off value of 97 ms in V1 had 84% sensitivity and 62% specificity (area under curve = 0.880).
CONCLUSION: In patients with VT of RV origin, the prolonged Tpe interval in sinus rhythm electrocardiogram supports the diagnosis of ARVC. ©2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  arrhythmogenic right ventricular cardiomyopathy; electrocardiography; ventricular outflow tract tachycardia; ventricular tachycardia

Mesh:

Year:  2014        PMID: 25041179     DOI: 10.1111/pace.12464

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Sympathetic nerve stimulation, not circulating norepinephrine, modulates T-peak to T-end interval by increasing global dispersion of repolarization.

Authors:  Daigo Yagishita; Ray W Chui; Kentaro Yamakawa; Pradeep S Rajendran; Olujimi A Ajijola; Keijiro Nakamura; Eileen L So; Aman Mahajan; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-22

2.  Evaluation of Tp-e Interval, Tp-e/QT Ratio, and Tp-e/QTc Ratio in Patients with Asymptomatic Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Elnur Alizade; Mahmut Yesin; Mehmet Vefik Yazicioğlu; Ekrem Bilal Karaayvaz; Adem Atici; Şükrü Arslan; Anıl Avci; Göksel Acar; Mustafa Tabakci; Servet Izci; Selçuk Pala
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

3.  Predictive value of Tpeak-Tend interval for ventricular arrhythmia and mortality in heart failure patients with an implantable cardioverter-defibrillator: A cohort study.

Authors:  Cong Xue; Wei Hua; Chi Cai; Li-Gang Ding; Hong-Xia Niu; Xiao-Han Fan; Zhi-Min Liu; Min Gu; Yun-Zi Zhao; Shu Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

4.  Precordial T-Wave Inversions in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy Who Present with the Initial Features of Right Ventricular Outflow Tract Arrhythmia.

Authors:  Fa-Po Chung; Cheng-I Wu; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Chin-Yu Lin; Ting-Yung Chang; Tze-Fan Chao; Jo-Nan Liao; Ta-Chuan Tuan; Ling Kuo; Chih-Min Liu; Chye-Gen Chin; Ying-Chieh Liao; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.